Biotia

Curated by Signal

Provider of sequencing-based solutions for hospitals

Overview

Provider of sequencing-based solutions for hospitals. The company uses its proprietary bioinformatics technology to fight nosocomial infections and other diseases. The company offers active surveillance of the highest risk units, and incoming patients, and facilitates intervention before patients get sick.

Key facts

Founded: 2016
Headquarters: Brooklyn, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

GTM channel: Sign up to view
4 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Freenome
Provider of a deep learning platform for detecting circulating cancer-related markers
Life Sciences TechnologyUnited States
BigHat
Provider of antibody therapies developed by machine learning and synthetic biology
Life Sciences TechnologySan Carlos, United States
Miist Therapeutics
Developer of advanced inhalation drug delivery system
Life Sciences TechnologyAlameda, United States

About Biotia

What does Biotia do?

Provider of sequencing-based solutions for hospitals.

Where is Biotia headquartered?

Biotia is headquartered in Brooklyn, United States.

When was Biotia founded?

Biotia was founded in 2016.

Which sector is Biotia in?

Biotia operates in Life Sciences Technology.

Who are Biotia's competitors?

Companies similar to Biotia include Freenome, BigHat, and Miist Therapeutics.